Combined AI and Experimental Validation Platform Enables End-to-End Protein Binder Discovery in 1-2 Weeks The updates create a comprehensive, end-to-end system that enables protein binder discovery in ...
Diffuse coronary artery disease is a subtype of coronary artery disease (CAD) in which larger sections of coronary arteries have a high plaque buildup. It is less common than focal CAD and can be more ...
SAN CARLOS, Calif., June 11, 2025--(BUSINESS WIRE)--Diffuse Bio, a leading provider of AI systems for designing protein therapeutics, today announced the public launch of DSG2-mini, its latest AI ...
SAN CARLOS, Calif.--(BUSINESS WIRE)--Diffuse Bio, a leading provider of AI and experimental platforms for designing and screening protein therapeutics, today announced significant enhancements to ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results